title: Inhaled insulin does not trigger lung inflammation and airway remodelling.
authors.forename: M
authors.initials: M
authors.lastname: Papagianni
authors.forename: A
authors.initials: A
authors.lastname: Hatziefthimiou
authors.forename: G
authors.initials: G
authors.lastname: Chachami
authors.forename: K
authors.initials: K
authors.lastname: Gourgoulianis
authors.forename: P-A
authors.initials: PA
authors.lastname: Molyvdas
authors.forename: E
authors.initials: E
authors.lastname: Paraskeva
mesh_terms: D000280:Administration, Inhalation; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D001999:Bronchoscopy; D002986:Clinical Trials as Topic; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007249:Inflammation; D007328:Insulin / Q000494:pharmacology*; D008168:Lung / Q000473:pathology; D010641:Phenotype; D012307:Risk Factors
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin